EP2326385A2 - Ensemble de port à utiliser avec un connecteur sans aiguille - Google Patents

Ensemble de port à utiliser avec un connecteur sans aiguille

Info

Publication number
EP2326385A2
EP2326385A2 EP20090791621 EP09791621A EP2326385A2 EP 2326385 A2 EP2326385 A2 EP 2326385A2 EP 20090791621 EP20090791621 EP 20090791621 EP 09791621 A EP09791621 A EP 09791621A EP 2326385 A2 EP2326385 A2 EP 2326385A2
Authority
EP
European Patent Office
Prior art keywords
perforator
port assembly
port
disposed
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20090791621
Other languages
German (de)
English (en)
Inventor
Steven C. Jepson
James B. Winje
Mark C. Perry
Gilbert Semaan
David D. Hsu
Dan Liu
Richard F. Chamernik
Eric J. Henaut
Gianni Di Stefani
Georges Rondeau
Lewis E. Daniels Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of EP2326385A2 publication Critical patent/EP2326385A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A61M39/26—Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1475—Inlet or outlet ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/10—Tube connectors; Tube couplings
    • A61M39/1011—Locking means for securing connection; Additional tamper safeties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/162—Needle sets, i.e. connections by puncture between reservoir and tube ; Connections between reservoir and tube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2044—Separating means having slits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2051—Connecting means having tap means, e.g. tap means activated by sliding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/10—Tube connectors; Tube couplings
    • A61M2039/1072—Tube connectors; Tube couplings with a septum present in the connector
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A61M39/26—Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • A61M2039/263—Valves closing automatically on disconnecting the line and opening on reconnection thereof where the fluid space within the valve is decreasing upon disconnection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A61M39/26—Valves closing automatically on disconnecting the line and opening on reconnection thereof
    • A61M2039/267—Valves closing automatically on disconnecting the line and opening on reconnection thereof having a sealing sleeve around a tubular or solid stem portion of the connector

Definitions

  • This patent is directed to a port assembly for use with a needleless connector, and, in particular, to a port assembly for use with a needleless connector wherein the port assembly includes an axial perforator.
  • Intravenous (“LV. ”) therapy involves the delivery of fluids to a patient through a vein.
  • a catheter is placed into the vein of the patient, and then fluids are administered to the patient through the catheter.
  • the catheter is connected to an administration set in communication with a container, such as a flexible container or bag, from which fluids are infused into the patient.
  • the flexible container conventionally has two ports, an administration port ("admin port”) and a medication port (“med port”), each port serving a different purpose.
  • the admin port is used to access the solution in the container to infuse fluid from the container into the patient.
  • the med port is used by a healthcare worker or a pharmacist to access the solution in the container to aspirate solution or to introduce medication and/or other substances (e.g.., nutritional supplements, vitamins, etc.) into the container.
  • the admin port is usually defined by a thermoplastic tube or chimney having a solid thermoplastic membrane, which membrane is disposed in the tube or chimney to prevent access to the solution in the container.
  • a sharp spike (such as may conform to International Organization for Standardization Standard ISO 8536-4) is inserted into the tube or chimney, and advanced along the tube or chimney to pierce the membrane. The spike is attached to the administration set, and thereby establishes fluid communication between the container and the set.
  • the med port conventionally includes a solid rubber septum that may be pierced using a needle, pointed cannula or other sharp instrument, such as a "reconstitution adapter.”
  • the sharp, pointed instruments used to access the solution in the container via the admin or med ports represent an accidental puncture hazard to the healthcare worker or the pharmacist using the instrument, as well as a hazard to the patient, the equipment (e.g., the container), and others involved in the patient's healthcare.
  • the traditional unshrouded sharp spikes used to access the admin port can cause damage to container upon spiking.
  • the spikes also present a puncture hazard to healthcare workers who handle the container as a waste container, especially where the container is a thin-film bag.
  • the present disclosure sets forth an improved assembly embodying advantageous alternatives to the conventional devices discussed above.
  • a fluid container includes a receptacle for retaining a fluid and at least one conduit in communication with the receptacle, the at least one conduit defined, at least in part, by a port assembly.
  • the port assembly includes a housing with an opening and a bore therethrough, a slit septum disposed in the bore to control access through the opening, a base joined to the housing and having a membrane attached thereto, a perforator having a first end abutting the slit septum and a second end aligned with the membrane, and a resilient member disposed between the perforator and the base.
  • the port assembly includes a housing with an opening and a bore therethrough, a slit septum disposed in the bore to control access through the opening, a base joined to the housing and having a membrane attached thereto, a perforator having a first end abutting the slit septum and a second end aligned with the membrane, and a resilient member disposed between the perforator and the base.
  • a needleless connector is provided.
  • the needleless connector includes a base, a luer tip having a first end attached to the base and a second, free end, and a shroud disposed about the luer tip and having a first end attached to the base and a second, free end, the second end of the shroud depending further from the base than the second end of the luer tip.
  • the shroud has an inner surface with a shoulder between the first end and the second end, and a threaded region formed on the inner surface of the shroud, the threaded region having a first end adjacent the base and a second end axially spaced from the shoulder in the inner surface of the shroud to define an unthreaded region therebetween.
  • FIG. 1 is a fragmentary, perspective view of an embodiment of a fluid container with a needleless port assembly
  • FIG. 2 is an exploded, perspective view of a port connector assembly as shown in Fig. 1;
  • FIG. 3 is an enlarged, cross-sectional view of the port connector assembly of Fig. 1 taken about line 3-3;
  • Fig. 4 is a fragmentary, enlarged, cross-sectional view of the port assembly with the perforator spaced from the inwardly-concave septum;
  • Fig. 5 is a fragmentary, enlarged, cross-sectional view of the port assembly with the perforator abutting the inwardly-concave septum;
  • Fig. 6 is an enlarged, cross-sectional view of a male needleless connector in use with the port assembly of Fig. 1 in a preparatory state;
  • Fig. 7 is a combination of the male needleless connector and the port assembly in an inserted state, after rupture of the membrane but prior to full extension;
  • Fig. 8 is a combination of the male needleless connector and the port assembly in an inserted state, after rupture of the membrane with full extension;
  • FIG. 9 is an enlarged, cross-sectional view of another port assembly
  • FIG. 10 is an enlarged, cross-sectional view of a further port assembly
  • FIG. 11 is an enlarged, cross-sectional view of yet another port assembly
  • FIG. 12 is a perspective view of a two-port fluid container with a port assembly introduced into one port tube;
  • FIG. 13 is a perspective view of a two-port fluid container with a port assembly introduced into both port tubes;
  • FIG. 14 is a perspective view of a one -port fluid container with a port assembly introduced into the port tube;
  • FIG. 15 is a perspective view of a two-port fluid container having a gondola with a port assembly introduced into one chimney;
  • FIG. 16 is a perspective view of a two-port fluid container having a gondola with a port assembly introduced into both chimneys;
  • FIG. 17 is an enlarged cross-sectional view of a port assembly, similar to that illustrated in Fig. 9, in combination with a chimney of a gondola, such as is shown in Figs. 15 and 16;
  • Fig. 18 is an enlarged cross-sectional view of another port assembly, similar to that illustrated in Fig. 9, in combination with a chimney of a gondola, such as is shown in Figs. 15 and 16;
  • Fig. 19 is an enlarged cross-sectional view of a positive displacement variant of a port assembly, similar to that illustrated in Fig. 9;
  • Fig. 20 is an enlarged cross-sectional view of the port assembly of Fig.
  • Fig. 21 is an enlarged cross-sectional view of the port assembly of Fig.
  • Fig. 22 is an enlarged end view of a perforator used in the port assembly according to Fig. 19;
  • Fig. 23 is a cross-sectional view of another perforator for use in the port assembly according to Fig. 19;
  • Fig. 24 is a cross-sectional view of a positive displacement variant of a port assembly, similar to that illustrated in Fig. 19;
  • Fig. 25 is a cross-sectional view of a port assembly according to a multilumen variant, similar to that illustrated in Fig. 9, in an med port state;
  • Fig. 26 is a cross-sectional view of the port assembly according to Fig. 25 in an admin port state;
  • Fig. 27 is an enlarged cross-sectional view of a multi-lumen perforator used in the embodiment of a port assembly illustrated in Figs. 25 and 26;
  • Fig. 28 is a cross-sectional view of a male needleless connector in combination with a connector for an administration set;
  • Fig. 29 is a cross-sectional view of a port assembly according to a positive displacement variant with a luer tip in pre-insertion state
  • Fig. 30 is a cross-sectional view of the port assembly of Fig. 29 immediately after insertion of the luer tip
  • Fig. 31 is a cross-sectional view of the port assembly of Fig. 29 with fluid passing from the luer tip through the port assembly;
  • Fig. 32 is a cross-sectional view of the port assembly of Fig. 29 as the luer tip is removed from the port assembly;
  • Fig. 33 is a cross-sectional view of a port assembly according to a positive displacement variant similar to the port assembly of Fig. 29;
  • Fig. 34 is a cross-sectional view of a port assembly according to a multilumen, positive displacement variant with a luer tip in a pre-insertion state;
  • Fig. 35 is a cross-sectional view of the port assembly of Fig. 34 after insertion of the luer tip;
  • Fig. 36 is a perspective view of a perforator for use in a port assembly, prior to a second step of a two-shot molding process;
  • Fig. 37 is a perspective view of the perforator of Fig. 36 after the second step of the two-shot molding process to define a valve thereon;
  • Fig. 38 is a cross-sectional view of a port assembly according to a multilumen, positive displacement variant incorporating the perforator of Fig. 36, with a luer tip in a pre-insertion state;
  • Fig. 39 is a cross-sectional view of the port assembly of Fig. 38 after insertion of the luer tip with the valve open;
  • Fig. 40 is a perspective view of another perforator for use in a port assembly, such as illustrated in Figs. 38 and 39, prior to a second step of a two-shot molding process;
  • Fig. 41 is a perspective view of the perforator of Fig. 40 after the second step of the two-shot molding process to define a valve thereon;
  • Fig. 42 is a cross-sectional view of the perforator of Fig. 40;
  • Fig. 43 is a perspective view of a further perforator for use in a port assembly, such as illustrated in Figs. 38 and 39, prior to a second step of a two-shot molding process;
  • Fig. 44 is a perspective view of the perforator of Fig. 43 after the second step of the two-shot molding process to define a valve thereon;
  • Fig. 45 is a cross-sectional view of the perforator of Fig. 43.
  • Fig. 1 illustrates a fluid container 100 according to the present disclosure.
  • the fluid container 100 includes a receptacle 102 for retaining a fluid, and at least one conduit 104 in communication with the receptacle 102.
  • the receptacle 102 is a flexible bag formed using a polymer.
  • the receptacle 102 could be a rigid- wall container, such as a glass bottle, or other container, such as a cartridge, unfilled flexible container, etc.
  • the fluid container of Fig. 1 is illustrated in combination with a first embodiment of a needleless port assembly, or port assembly, 106.
  • the port assembly 106 is disposed in a port tube, as illustrated, to define the conduit 104.
  • the port assembly 106 may include one or more structures that are integral with the remainder of the conduit 104, as illustrated and explained below.
  • the port assembly 106 includes a housing 108 with an opening 110 and a bore 112 therethrough (see Figs. 2 and 3).
  • An overmolded slit septum 114 depends through the opening 110 and into the bore 112 to control access through the opening 110.
  • a base 116 is joined to the housing 108 and has a membrane 118 attached thereto (see Fig. 3).
  • the port assembly 106 also includes a perforator 120 having a first end 122 abutting the slit septum 114 and a second end 124 aligned with the membrane 118.
  • a resilient member 126 is disposed between the perforator 120 and the base 116, biasing the perforator 120 from the membrane 118.
  • the inner surface 130 and the outer surface 132 have different radii of curvature, as illustrated.
  • the radius of curvature, or simply “the curvature,” of the outer surface 132 is greater than the curvature of the inner surface 130. It will be recognized that this is simply an embodiment according to the present disclosure, and that other septum shapes may be used as well, such as an embodiment wherein the inner and outer surfaces 130, 132 have similar radii of curvature, or where the differences in curvature are greater than are illustrated.
  • the slit septum 114 shaped as illustrated may be referred to as an inwardly-concave overmolded slit septum. An inwardly-concave overmolded slit septum has certain advantages relative to conventional slit septums.
  • Certain conventional slit septums rely on a compression seal between a rigid housing (which may be made of metal, glass or plastic, for example) and the septum.
  • a separate, individually-fabricated, oversized septum is disposed into an entrance of the housing, the outer diameter of the septum being greater than the inner diameter of the entrance of the housing.
  • the septum may be attached to the housing mechanically (crimping, swaging, or threading, for example) or through the use of an adhesive, which attachment mechanisms may contribute to the compression seal.
  • mechanical attachment is a challenge because of the dimensional constraints defined in ISO 594, and adhesive attachment creates manufacturing reliability challenges, especially for steam- sterilized applications.
  • the inwardly-concave slit septum permits use of overmolding, thus eliminating the need for mechanical or adhesive attachment, while limiting the tension created when a flat overmolded septum is used.
  • the inwardly-concave septum reduces the slit opening effect from post-mold shrinkage by allowing shrinkage of septum material in the axis of the septum rather than only perpendicular to the axis. The result is a septum with less stored strain energy, resulting in a lesser degree of separation when the septum is slit.
  • further improvements may be possible when the inwardly- concave overmolded slit septum is supported from within by a concave surface.
  • the resilient member 126 biases the first end 122 of the perforator 120 into engagement with the slit septum 114.
  • the first end 122 of the perforator 120 is concave, similar to the septum 114 and particularly the inner surface 130.
  • the curvature of the first end 122 may be substantially similar to the curvature of the inner surface 130, as illustrated, so that the curvatures are mating.
  • the engagement between the first end 122 and the inner surface 130 causes the flattening of the outer surface 132 from its initial shape (compare Figs. 4 and 5).
  • the distance of travel of the inner surface 130 between the state illustrated in Fig. 4 and that illustrated in Fig. 5 may be referred to as the assembly flexing distance.
  • the flattening of the outer surface 132 need not result in a planar surface; some degree of curvature may remain.
  • the flattening of the outer surface 132 of the septum 114 improves the ability of the septum 114 to be cleaned prior to use by swabbing or disinfecting according to conventional techniques.
  • the cooperation of the perforator 120 and the septum 114 may have other effects, other than simply causing the flattening the outer surface 132.
  • the flattening of the septum 114 also may concentrate forces on the slit, assisting in establishing a compression seal on the slit. It will be recognized, that excessive force applied to the septum 114 may actually result in spreading the septum, causing a separation to form along the slit, so there is a balance of forces involved.
  • the cooperation of the perforator 120 and the septum 114 may result in a seal that is resistant to high or low pressure from fluid within in the container.
  • the slit septum 114 includes a sleeve 134 having first and second ends 136, 138, as will be noted in Fig. 3. Further, the septum 114 includes an inwardly depending ring 142 disposed at the second end 138 of the sleeve 134. The inwardly depending ring 142 abuts an outer surface 144 of the perforator 120 to form the equivalent of an O-ring seal with the outer surface 144 to limit leakage of injected medication into the spaces outside the perforator 120. This seal is beneficial as the interface between a luer stem or tip and the first end 122 of the perforator 120 would not otherwise typically provide a sealing relationship and would add to the residual volume of the port assembly 106.
  • the perforator 120 has a flange 150 and a hollow tube or cannula 152 that depends from the flange 150 to the second end 124 of the perforator 120.
  • the cannula 152 ends in a pointed profile 154.
  • the resilient member 126 spaces the second end 124 of the perforator 120, and in particular the pointed profiled 154, from the membrane 118, and in part determines the size of the force required to move the second end 124 of the perforator 120 into contact with the membrane 118 to rupture the membrane 118 as a needleless connector is advanced into the slit septum 114. See Figs. 6-8.
  • the pointed profile 154 may have one or more apertures 156 through which fluid may pass when the perforator 120 penetrates the membrane 118; a single aperture is illustrated in the embodiment illustrated.
  • the resilient member 126 is defined by a flexible tube 158 with a passage 160 therethrough.
  • the cannula 152 of the perforator 120 is received within the passage 160 in the flexible tube 158 that defines the resilient member 126.
  • the resilient member 126 may have an outer shape that assists in permitting the resilient member 126 to flex without crushing; according to one such embodiment, the cross section of the resilient member 126 in a plane perpendicular to the plane of the page would appear as an eight-pointed star with a circular hole in the center. See Fig. 2.
  • the resilient member 126 is also designed to limit potential residual volume around the cannula 152.
  • the resilient member 126 forms a liquid-tight, hermetic seal about the cannula 152 to limit leakage of medication into the space about the cannula 152.
  • the flange 150 may have a stepped shoulder 162, the stepped shoulder 162 being disposed inside with a first end 164 of the resilient member 126.
  • the base 116 may include a cylindrical collar 166 that defines a shoulder 168, collar 166 being disposed inside a second end 170 of the resilient member 126 abutting the shoulder 168.
  • the resilient member 126 may have a smaller inner diameter than an outer diameter of the stepped shoulder 162 of the perforator 120 or the collar 166 of the base 116, and may expand to accommodate the stepped shoulder 162 and the collar 166 within the resilient member 126. As stated above, the seals thus formed limit leakage out of the space between the resilient member 126 and the cannula 152, which leakage may prevent medication from entering the container 100 and reduce the delivered dose.
  • the cylindrical collar 166 also defines a passage 174 in which the pointed profile 154 of the perforator 120 is received to align the pointed profile 154 with the membrane 118. As illustrated, the passage 174 is adjacent a recess 176 in a surface 178 of the base 116.
  • the cup-shaped membrane 118 is formed in the recess 176, by heat sealing or a two-shot molding process, for example, so that a wall 180 of the membrane 118 spans an opening 182 defined between the passage 174 and the recess 176. In this fashion, the wall 180 of the membrane 118 is aligned with the pointed profile of the perforator 120 to facilitate the proper penetration of the membrane 118 by the perforator 120.
  • FIG. 6-8 The operation of the embodiment of the port assembly 106 is now discussed with reference to Figs. 6-8.
  • the port assembly 106 is illustrated in Figs. 6-8 in combination with a male needleless connector 200, which cooperates with the port assembly 106 to move the perforator 120.
  • the connector 200 represents a non-conventional luer-type connector, which may be used with other LV. administration sets, syringes, or other ancillary devices such as reconstitution adapters, as well as with the port assembly 106.
  • the port assembly 106 may be used with conventional luer-type devices, such as syringes or LV. tubing connectors, having dimensions in accordance with International Organization for Standards Standard ISO 594.
  • non-conventional and conventional connectors may have a threaded region, such a connector being referred to as a "luer lock”; however, according to certain embodiments of the present disclosure, the connectors may lack a threaded region, such a connector being referred to as a "slip luer.”
  • the connector 200 has a luer stem or tip 202 that is surrounded by a threaded region 204. More particularly, an extended shroud or skirt 206 is disposed about the luer tip 202, the shroud 206 being attached, with the luer tip 202, to a common base at one end and depending further from the base than the luer tip 202 at the other, according to the illustrated embodiment.
  • the shroud 206 has an inner surface on which the threaded region 204 is formed.
  • the threaded region 204 of the connector 200 is intended to cooperate with threads 208 on an outer surface 210 of the housing 108.
  • the penetration depth of the luer stem 202 is thus proportional to the amount of rotation applied to the connector 200.
  • the connector 200 is designed to provide increased penetration depth for the luer stem 202 into the port assembly 106.
  • the increased penetration depth is intended to provide for increased exposure of the apertures 156 as the pointed profile 154 penetrates the membrane 118 and displaces the portion of the membrane 118 so penetrated (the "membrane flap").
  • Increased exposure of the apertures 156 may lead, in turn, to increased flow rate when using the connector 200 as illustrated in comparison with use of a conventional luer-type device in accordance with ISO 594.
  • the connector 200 includes an unthreaded, or plain, region 212, which is best seen in Fig. 6.
  • the unthreaded region 212 is defined between an end of the threaded region 204 and a shoulder formed in the inner surface of the shroud 206.
  • the unthreaded region 212 causes the threaded region 204 to be recessed from the end of the connector 200. Because, as mentioned above, the penetration depth is otherwise proportional to the amount of rotation applied to the connector 200, the unthreaded region permits the end of the luer stem 202 to be disposed into the port assembly 106 prior to engagement of the threaded regions 204, 208 of the connector 200 and the port assembly 106.
  • the distance may be, for example, the equivalent of a half turn to a full turn of the connector 200 relative to the port assembly 106.
  • This arrangement avoids requiring the user to apply more rotation to achieve increased penetration, and may even be combined with a luer stem length in excess of that required by ISO 594 to provide even greater penetration.
  • the connector 200 includes a shroud or skirt 206. This shroud 206 cooperates with a flange 214 arranged on the outer surface of the port assembly 106. The combination of the shroud 206 and the flange 214 provides a further, unique feature of the connector 200, which may be used in combination with the unthreaded region 212, or separately from that feature, to the advantage of the user.
  • the connector provides tactile feedback to the user regarding the progression of the connector on to the mating structure through gradual resistance to further tightening.
  • the combination of the shroud 206 and the flange 214 provides a visual indication in combination with such tactile feedback. That is, when the threaded regions 204, 208 have fully engaged, the user is highlighted to this fact through the abutment of the shroud or skirt 206 and the flange 214.
  • the flange 214 may include an annular groove 216, in which the shroud 206 is disposed as the threaded regions 204, 208 become fully engaged.
  • the groove 216 may have a slight taper from an open end to a closed, or blind, end to improve the tactile feedback.
  • the groove may also define a seal between the shroud 206 and the flange 214, which seal may further limit leakage from the combination of the connector 200 and the port assembly 106.
  • Further improvements in the sealing between the shroud 206 and the flange 214 may be provided by disposing a gasket between the shroud 206 and the flange 214.
  • This gasket may be used with the groove 216, or may be used as a separate feature.
  • the gasket may be made separately from the shroud 206 or the flange 214 and attached thereto, or the gasket may be formed on one of the facing surfaces of the shroud 206 and flange 214 through the use of a two-shot molding process, for example.
  • one or more apertures may be defined in the wall of the housing 108 so that the same material that is used to form the slit septum 114 may be permitted to flow through the housing 108 and over the flange 214 to define the gasket thereon.
  • gasket-defining material may enhance the friction between a rim of the shroud 206 and a surface of the flange 214 when the structures cooperate.
  • the additional resistance provided may result in additional tactile feedback to limit further rotation.
  • the frictional cooperation between shroud 206 and flange 214 may be further enhanced through snap ribs, slots or other structure disposed on one or both of the shroud 206 and the flange 214, which features may be used with the one or both of the groove 216 and gasket, or may be used independently.
  • the frictional cooperation of the shroud 206 and the flange 214 may also provide increased connection security, in that the additional resistance to rotation in the direction of further tightening also results in additional resistance to rotation in the direction of disengagement.
  • other structures may be used to the shroud 206 and the flange 214 to reduce friction between the structures.
  • the use of the shroud 206 may provide other advantages.
  • the shroud 206 may limit the potential for touch contamination of the luer 202 of the connector 200.
  • the shroud 206 may aid in alignment upon connection, and to this end alignment ribs may be included inside the shroud 206; for example, four to eight ribs may be disposed within the shroud 206 to assist in alignment.
  • a flexible "drip chamber" may be attached to the connector 200 to connect the connector 200 to tubing of an LV. administration set.
  • the connector 200 may be connected directly to the administration set.
  • the luer stem 202 is just coming into contact with the slit septum 114.
  • the resilient member 126 is biasing the perforator 120, and in particular the pointed profile 154, away from the wall 180 of the membrane 118.
  • the resilient member 126 will continue to bias the pointed profile 154 of the perforator 120 away from the wall 180 of the membrane as the luer stem 202 is advanced into the slit septum 114, the threads 208 of the housing 108 interacting with the threaded region 204 of the male connector 200.
  • the force applied to the first end 122 of the perforator 120 causes the pointed profile 154 to rupture the wall 180 of the membrane 118, as shown in Fig. 7.
  • the pointed profile 154 then proceeds to pass by the membrane 118 into the fluid container.
  • the threads 208 of the housing 108 continue to interact with the threaded region 204 of the male connector 200, more and more of the aperture 156 is exposed, without partial occlusion caused by the base 116 or part of the membrane 118, such as the membrane flap.
  • the threads 208 of the housing 108 and the threaded region 204 of the male connector 200 have now cooperated to their maximum extent.
  • the pointed profile 154 now depends past the membrane 118 and base 116, such that the aperture 156 is in fluid communication with the receptacle 102 without occlusion caused by the base 116. It will be recognized that as the when the luer stem 202 of the male connector 200 is withdrawn from the port assembly 106, the perforator 120, and thus the pointed profile 154 and associated aperture 156, will be withdrawn into the base 116, which will then again partially occlude the flow of fluids through the perforator 120.
  • FIG. 9 The embodiment of Figs. 1-8 is but a single embodiment of the port assembly according to the present disclosure.
  • Other embodiments are illustrated in Figs. 9-11. It will be recognized, however, that aspects of the embodiments illustrated in the Figs. 9-11 may be used with the embodiment of Figs. 1-8, and vice versa.
  • the elements of the various embodiments may be used in combination with each other.
  • the integrated resilient member and membrane illustrated in Fig. 9 may be used in combination with the variant in regard to the cooperation between the septum and perforator illustrated in Fig. 10, as will be recognized.
  • Other variations are possible.
  • the structure of the port assembly 300 is similar to that illustrated in Figs. 1-8 as relates to the housing 302, the septum 304, and the perforator 306.
  • the base 308, resilient member 310 and membrane 312 of the embodiment of Fig. 9 differs significantly from that of Figs. 1-8.
  • the resilient member 310 includes a flexible tube 314 with an open end 316 in which a cannula 318 of the perforator 306 is received, much like the embodiment illustrated in Figs. 1-8.
  • the resilient member 310 also includes a closed end 320.
  • the closed end 320 is formed in the base 308, by a two-step molding process, for example, and defines the membrane 312.
  • the closed end 320 of the resilient member 310 includes a flange 322 that defines a shoulder 324.
  • the shoulder 324 seats against a surface 326 of the base 308 to position the section of the flexible tube 314 that acts as the resilient member 310.
  • the flexible tube 314 depends past the surface 326 of the base 308, and through a passage 328.
  • a wall 330 depends across the tube 314 at an end 320 of the tube 314 within the passage 328, thereby defining the membrane 312.
  • the tube 314 thus provides some of the features of the collar 166 in the embodiment illustrated in Figs.
  • the tube 314 aligns the perforator 120 with the membrane 312, at the same time the wall 330 formed with the tube 314 defines the membrane 312.
  • the assembly 300 may then be secured in place onto the LV. container through connection to a flexible port tube 332, which is connected to the remainder of the container.
  • FIG. 10 Another embodiment of a port assembly 400 is illustrated in Fig. 10.
  • the differences in regard to the other embodiments primarily relate to the cooperation between the slit septum 402 and a first end 404 of a perforator 406, although it should be noted that the angled profile of the perforator 406 is also different from the pointed profile illustrated in Figs. 1-9.
  • An advantage of the angled profile of the perforator 406 is that is may provide maximum aperture exposure at limited penetration distances, in accordance with the bevel angles and the non-concentric or offset lumen of perforator 406.
  • the slit septum 114 has an inwardly directed ring 142 that cooperates with a surface 144 of the perforator 120 to seal the septum 114 and perforator 120 to limit infiltration into and out of the space between the surfaces 144, 146 of the perforator 120 and septum 114.
  • the slit septum 402 includes a sleeve 404 having first and second ends 406, 408.
  • the perforator 410 includes a first end 412 with an outwardly- depending wiper 414.
  • the outwardly-depending wiper 414 abuts an inner surface 416 of the sleeve 404, and forms a seal therebetween to prevent leakage.
  • the embodiment of Fig. 10 may have one or more advantages relative to the embodiment illustrated in Figs. 1-8.
  • the sleeve 404 may have a thicker wall thickness than that illustrated in Figs. 1-8.
  • the increased wall thickness may aid the overmolding of the septum 402.
  • the removal of the ring from the sleeve further simplifies the overmolding process.
  • the removal of the ring limits or reduces the residual volume relative to the embodiment of Figs. 1-8.
  • the outwardly- depending wiper 414 may provide positive displacement of liquid contents upon withdrawal of the associated connector, the importance of which is explained in greater detail below.
  • the difference in regard to the other embodiments relates to the shape of the end 502 of the perforator 504 that punctures the membrane 506.
  • the end 502 of the perforator 504 has a blunt profile, in contrast with the pointed profile 154 illustrated in the embodiments disclosed in Figs. 1-9 or the angled profile illustrated in the embodiment disclosure in Fig. 10.
  • the perforator 504 includes a cannula 508, this cannula 508 ends not in an angled point, but in a plate 510 that lies in a plane perpendicular to the axis of the cannula 508.
  • the plate 510 may be equipped with a point 514 to assist the blunt profile of the first end 502 of the perforator 504, as is illustrated, the profile of the perforator 504 remains blunt.
  • the cannula 508 may include one or more apertures 512.
  • the plate 510 may have a periphery with an outer diameter greater than the inner diameter of the resilient member 126, and may thus form a liquid-tight seal.
  • the plate 510 and the resilient member 126 need not form a liquid-tight seal.
  • the plate 510 and the resilient member 126 may form a liquid- tight seal, and this seal may permit the membrane 506 to be removed altogether.
  • a needleless port assembly according to any of the embodiments described above may be incorporated into a fluid container according to any of a variety of configurations.
  • Figs 12-14 illustrate embodiments wherein a fluid container includes a port tube, the port assembly disposed in the port tube to define the conduit.
  • Figs. 15 and 16 illustrate embodiments wherein a fluid container includes a gondola, the gondola including a chimney that is formed integrally with the base of the port assembly to define the conduit.
  • the port assemblies would have sterile port protectors or caps covering the ends; the caps have not been shown to facilitate visualization of the port assembly placement.
  • the port assembly may have a peelable foil seal disposed over the opening as a sterility protector.
  • Fig. 12 illustrates an embodiment wherein the port assembly is utilized in the med port, and another mechanism, such as a conventional spike, is used in the admin port.
  • Fig. 13 illustrates an embodiment wherein a port assembly according to the present disclosure is utilized in both the admin and the med ports.
  • Fig. 14 illustrates an embodiment wherein the port assembly is utilized in a single port embodiment.
  • Fluid containers utilizing gondolas have a similar convention relative to the designation of med and admin ports, the inclusion of the gondola coming about because of difficulties in joining the chimney material to the receptacle material.
  • Fig. 15, like Fig. 12, illustrates an embodiment wherein the port assembly is utilized in the med port.
  • Fig. 16, like Fig. 13 illustrates an embodiment wherein the port assembly is utilized in the admin and med ports.
  • the base may be formed integrally (i.e., as one piece) with the gondola, as discussed above.
  • a port assembly 600 may be connected to a gondola without forming any part of the port assembly integrally (i.e., as one piece) with the gondola.
  • the port assembly 600 includes a housing 602, a slit septum 604, a perforator 606, a base 608, a resilient member 610 and a membrane 612, all similar to the port assembly of Fig. 9.
  • the resilient member 610 and the membrane 612 are formed integrally with each other.
  • the resilient member 610 includes a flexible tube 614 with an open end 616, in which a cannula 618 of the perforator 606 is received, and a closed end 620.
  • the closed end 620 defines the membrane 612.
  • the resilient member 610 and the membrane 612 are formed with the base 608 using a two-step molding process, for example.
  • the base 608 includes at least one lug or hook 622. As illustrated, the base 608 includes two hooks 622, which depend from the base 608 from an outer surface 624.
  • hooks 622 may cooperate with features of a chimney 630 to limit the separation of the base 608 from the chimney 630, thereby attaching the port assembly 600 to the chimney 630.
  • the chimney has a flange 632 with a surface 634.
  • Each hook 622 may have a surface 636 that cooperates with the surface 634 of the chimney flange 632 such that the port assembly 600 can not move about its axis (rotation) or vertically (translation).
  • the combination may include features to limit leakage between the port assembly 600 and the chimney 630.
  • a gasket 640 may be formed through a two-step molding process on the flange 632, although it will be recognized that this gasket may alternatively be formed separately from the flange 632 and disposed in the chimney 630. As a further alternative, the gasket 640 may be formed on the base 608. The gasket 640 is disposed between the base 608 and the chimney flange 632, and in particular between opposing surfaces 624, 642 of the base 608 and chimney flange 632 so that the surfaces 624, 642 abut the gasket 640 as assembled. The gasket 640, in conjunction with the chimney 632, ensures the fluid-tightness of the assembly. [00105] It will be recognized that variants to the embodiment illustrated in Fig. 17 are possible.
  • a port assembly 650 is illustrated in Fig. 18.
  • the port assembly 650 no gasket is disposed between opposing surfaces of a base 652 of the port assembly 650 and a flange 654 of a chimney 656 of the gondola.
  • the base 652 of the port assembly 650 has a groove 660 formed in an outer surface 662 of the port assembly 650, and a sealing member 664 is disposed in the groove 660.
  • the sealing member 664 which may be in the form of an O-ring, is disposed between the base 652 and an inner surface 666 of the chimney 656 to limit fluid leakage past the port assembly.
  • the use of the above-mentioned port assembly, according to any of the various embodiments described herein, as the med port for a container may provide one or more of the following advantages relative to conventional med ports.
  • the use of the port assembly as described herein eliminates the use of sharp instruments, such as needles and reconstitution adapters, as have been used with conventional med ports, thereby eliminating the hazard posed to the pharmacist and the equipment (e.g., the container).
  • the lumen size of a luer is typically significantly larger than the lumen size of needles used with the conventional med ports, there may be a reduced force required to aspirate solution or to inject a substance into the container via the port assembly.
  • the port assemblies according to the present disclosure are expected to be significantly more durable relative to conventional med ports, given the quality of the reseal possible with a slit septum to a septum that may be repeatedly perforated in use.
  • port assembly may provide one or more of the following advantages relative to conventional admin ports.
  • Replacement of the conventional admin port with the port assemblies according to the present disclosure would eliminate use of the conventional sharp spike, thereby eliminating a potential puncture hazard to equipment, patients, and healthcare workers.
  • the administration set may now be connected to the container through the threaded engagement of a male luer connector attached to the set to the port assembly as disclosed, accidental disconnects may be limited.
  • the threaded engagement of the luer connector to the port assembly according to the present disclosure may provide a discrete feedback to the healthcare worker of complete connection, limiting "no-flow" medication errors.
  • the port assemblies according to the present disclosure would limit the ergonomic difficulties in fitting the conventional spikes into flexible tubes or chimneys. Further, the port assemblies disclosed here reseal after disconnection of the connector, which may prevent leakage currently occurring after disconnection of a conventional sharp spike from a conventional admin port.
  • the port assemblies according to the present disclosure facilitate use of a single port as admin port and med port. That is, convention admin ports did not have a resealable membrane, such that once the membrane was ruptured, leakage would occur. This presents an obstacle to use of conventional admin ports as med ports, which by the nature need to be resealable. Similarly, conventional med ports required a sharp, pointed instrument, such as a needle, to penetrate the septum. The flow rates possible through a needle are insufficient to permit connection of the administration set to the container in this fashion. However, because a male luer will provide flow rates sufficient for use of the port assembly as an admin port, the same luer- activated port assembly used first as a med port may later be used as an admin port as well.
  • the medication in or about the port may define a bolus of concentrated medication that may be delivered to the patient when the port is used as the admin port. Unless the bolus is mixes or dilutes in the administration set, it may be possible for the bolus to be delivered to the patient in the early stage of infusion. Such a bolus may have an undesired, even adverse, effect in the patient
  • the degree to which the medication remains in or about the med port may depend on features of the med port system (including the geometry and/or volume of the port and the length and/or position of the instrument used to inject medication into the port) as well as the techniques used (including the injection technique and the mixing technique).
  • the port assemblies according to the present disclosure use an instrument in the form of, for example, a luer tip on a syringe.
  • a conventional luer tip is typically much shorter than a needle, which may increase the potential for medication to be inadvertently left in or about the med port.
  • the dimensions of the structures of the port assemblies, as well as the seals formed between these structures as described in greater detail above, may be used to limit the residual volume of the assemblies, thereby limiting reductions in the dose recovery fraction or increases in the potential for bolus infusion.
  • a tradeoff remains between minimizing residual volume, thereby maximizing dose recovery or minimizing bolus infusion risk, and ensuring adequate flow rate through the single lumen perforator illustrated above. Consequently, it may be necessary to consider additional features.
  • the embodiments discussed above may additionally include one or more features that address the issues of dose recovery and bolus infusion, even when a conventional luer tip is used.
  • the embodiments illustrated in Figs. 1-8 and Fig. 9 the pointed tip of the perforator projects well beyond the membrane so as to maximize the potential for delivery of the medication or other substance injected therethrough into the container where it will become mixed with the other fluids in the container.
  • the offset or non-concentric perforator lumen may allows greater lumen exposure at a limited axial penetration depth, again so as to maximize the potential delivery of medication injected therethrough, while the wiper may provide positive displacement of the contents upon withdrawal of the associated connector, which positive displacement may increase dose recovery and reduce potential for bolus infusion.
  • Fig. 11 may also work to increase dose recovery and reduce potential for bolus infusion by limiting the amount of residual volume in the port assembly through the presence of the plate 510.
  • any of the embodiments discussed above may be combined with still further features that operate to increase dose recovery and reduce the potential for bolus recovery.
  • the embodiments of the port assembly illustrated in Figs. 19-24 address features for creating positive displacement, so as to automatically flush the port assembly after injection.
  • the embodiment of the port assembly illustrated in Figs. 25-27 includes a multi-lumen perforator, with different lumens used when the port assembly is used either as a med port or an admin port. It is believed that these additional features may further improve dose recovery or reduce the potential for bolus infusion.
  • a port assembly 700 is illustrated therein. Similar to the other port assemblies disclosed herein, the port assembly 700 includes a housing 702, a slit septum 704, a base 706, a perforator 708, a resilient member 710, and a membrane 712.
  • the slit septum 704 is overmolded on the housing 702, and operates to control passage through the port assembly 700.
  • the housing 702 is attached to the base 706 with the perforator 708 biased against the septum 704 and away from the membrane 712 by the resilient member 710. Similar to the embodiment illustrated in Figs. 9, 17, and 18, the resilient member 710 and the membrane 712 are molded as a single piece with the base 706 using a two-shot molding process, for example.
  • the port assembly 700 differs from the port assemblies previously discussed in relation to the shape and structure of the perforator 708.
  • the perforator 708 has a first end 720, which abuts the septum 704 in the standby state illustrated in Fig. 19, and a second end 722, which is pointed and is spaced from the membrane 712 in the standby state.
  • the first end 720 of the perforator 708 includes a plurality of passages defined by grooves 724 disposed about the circumference of the first end 720; while four grooves 724 are illustrated in Fig. 22, a lesser or a greater number of grooves may be used in any particular embodiment.
  • a flange 726 In between the first end 720 and the second end 722 is a flange 726.
  • a flexible, elastomeric gasket 728 is disposed on the flange 726; the gasket 728 may be formed separately and fitted onto the flange 726, or the gasket 728 may be formed on the flange 726, through a two-step molding process, for example.
  • the port assembly 700 also differs from certain of the port assemblies previously discussed in relation to the shape and structure of the slit septum 704.
  • the septum 704 includes a sleeve 730 having a first end 732, a second end 734, and an inner surface 736.
  • the second end 734 of the sleeve 730 does not have a structure formed thereon to abut and seal against an outer surface 738 of the perforator 708.
  • the inner surface 736 may be spaced between the first end 732 and the second end 734 of the sleeve 730 from the outer surface 738 of the perforator 708.
  • the spacing may be constant between the first end 732 and the second end 734 of the sleeve 730, or the spacing may be larger in certain regions, while smaller in other regions.
  • the inner surface 736 and the outer surface 738 may abut over certain regions; however, a fluid path should be maintained between the first end and the second end of the sleeve 730.
  • the perforator 708 cooperates with the septum 704, as well as the housing 702, to provide a positive displacement according to the following fashion.
  • an instrument for example a luer tip 750
  • the perforator 708 is advanced along the housing 702 in the direction of the membrane 712.
  • the perforator 708 is advances so that the second, pointed end 722 of the perforator 708 punctures the membrane 712, as illustrated in Fig. 20.
  • fluid may now flow, for example, through the luer tip 750 into the perforator 708, and from the perforator 708 into a container 752 associated with the port assembly 700.
  • fluid may be drawn from the container 752.
  • a space 754 opens between the outer surface 738 of the perforator 708 and an inner surface 756 of the housing 702. This opening space 754 is believed to create a vacuum, which pulls fluid into the space 754 to fill it. While some material may be pulled from the luer tip 750, it is believed that the fluid may be mainly drawn from the container 752, which is typically a thin-walled flexible bag, providing little resistance to the movement of the fluid in contrast to the rigid-walled syringe associated with the luer tip 750.
  • a perforator 770 is illustrated in Fig. 23, which perforator 770 may be used with the port assembly 700.
  • the perforator 770 differs from the perforator 708 as to the structure responsible for sealing the space 754 defined between the perforator and the housing.
  • the perforator 770 includes a pair of flanges 772, 774 that define a slot or groove 776 therebetween.
  • a sealing member 778 such as an O-ring, may be disposed in the slot 776, and may cooperate with an inner surface of the port assembly housing to limit fluid flow from the space defined between the perforator 770 and the housing.
  • a port assembly 800 includes a housing 802, a slit septum 804, a base 806 and a perforator 808 biased between the housing 802 and the base 806 by a resilient member 810.
  • the perforator 808, like the perforator 708, may have a plurality of grooves formed in a first end 820. Also, like the perforator 708, the perforator 808 may have a flange 822. However, the flange 822 does not have a sealing member associated therewith, such as perforators 708, 770 illustrated in Figs. 19-23. Instead, the septum 804 has a sleeve 824 that depends further into the housing 802 than in the embodiments illustrated in Figs. 19-22. The sleeve 824 is made of a resilient material, and cooperates with an edge 826 of the flange 822 to form a seal therebetween.
  • Figs. 25-27 provide an alternative port assembly 900 that addresses the issues of dose recovery and bolus infusion in a different manner than the embodiments illustrated in Figs. 19-24, which rely in part on positive displacement as discussed above.
  • the port assembly 900 relies instead on a multi-lumen perforator instead of the single lumen perforator described above.
  • the port assembly 900 includes a housing 902, a slit septum 904, a base 906, a perforator 908, and a resilient member 910.
  • the resilient member 910 and the membrane would be formed as a single piece with the base 906 using a two- shot molding process, for example, similar to many of the other port assemblies described herein.
  • the septum 904 includes a sleeve 912 having first and second ends 914, 916. Further, the septum 904 includes an inwardly depending ring 918 disposed at the second end 916 of the sleeve 912.
  • the inwardly depending ring 918 abuts an outer surface 920 of the perforator 908 to form the equivalent of an O-ring seal with the outer surface 920 to limit leakage of injected medication into the spaces outside the perforator 908.
  • the port assembly 900 is similar to other port assemblies described above.
  • the perforator 908 is different than all of the perforators described heretofore in that the perforator 908 includes more than one lumen. Specifically, the perforator 908 includes a first lumen 922 and a second lumen 924. Both lumens 922, 924 are offset from a longitudinal axis 926 of the perforator 908.
  • both lumens 922, 924 have at least one aperture 928, 930 formed in a first end 932 of the perforator 908.
  • the first lumen 922 has a smaller cross- sectional area in a plane orthogonal to the axis 926 than the second lumen 924.
  • the aperture 928 associated with the first lumen 922 is disposed closer to an apex 934 of the end 932 than the aperture 930 associated with the second lumen 924, and the aperture 928 is aligned parallel to the axis 926, while the aperture 930 is disposed orthogonal to the axis 926.
  • a first luer lock 940 is combined with the port assembly 900, the first luer lock 940 having dimensions in accordance with International Organization for Standards Standard ISO 594.
  • the first luer lock 940 has a luer tip 942 that abuts a second end 944 of the perforator 908 to cause the perforator 908 to perforate the membrane and provide access to an associated container.
  • the aperture 928 associated with the lumen 922 is exposed and fluid may flow through the lumen 922.
  • the aperture 930 remains covered by an internal surface 950 of the resilient member 910/membrane structure.
  • the luer lock 970 has a luer tip 972, which luer tip 972, when combined with the port assembly 900, causes the perforator 908 to advance further into the container 946 than the luer tip 942 associated with the luer lock 940, given that the luer tip 972 is longer than that specified by ISO 594. According to this state, both apertures 928, 930 are exposed, permitting fluid to flow from the luer tip 972 through either lumen 922 or lumen 924. This is advantageously provides a larger cross-sectional area, collectively, for fluid flow in the second operation state than the first operational state.
  • the first operational state which may correspond to an operational state wherein medication is injected into the container 946
  • a smaller cross-sectional lumen 922 is available for fluid communication between an instrument, such as the luer lock 940, and the container 946.
  • an instrument such as the luer lock 940
  • the second operational state which may correspond to an operational state wherein fluid is infused to the patient, a larger collective cross- sectional area passage is available.
  • the amount of medication retained in the lumen 922 may even be diluted to some extent as the fluid passes through both lumens 922, 924 and into the luer tip 972.
  • the considerations of dose recovery and bolus infusion may be balanced against adequate fluid flow.
  • Figs. 25 and 26 limits the potential for use of the luer lock 940 in place of the luer lock 970 when connecting an administration set to the container associated with the port assembly 900. If a luer lock 940 is used to connect an administration set to the container associated with the port assembly 900, it is likely that (i) a decreased flow rate relative to a desired flow rate will be observed and/or (ii) an upstream occlusion alarm associated with an IV pump may be triggered because only the lumen 922 is open. In either eventuality, it is believed that the luer lock 940 will then be replaced with the luer lock 970, which will provide adequate flow rate while addressing bolus effect and dose recovery.
  • the luer lock 970 may be shaped so as to close off the lumen 922 at the same time as uncovering the aperture 930, thereby opening the lumen 924.
  • the luer tip 972 of the luer lock 970 may have a structure that fits over or into the end of the lumen 922 closest to the luer tip 972.
  • the inner diameter of the luer tip 972 may be sized so as to be smaller than the inner diameter of the luer tip 942 of luer lock 940, such that the rim of the luer tip 972 closes off the lumen 922.
  • a projection may be formed on the luer tip 972 that closes off the lumen 922 when the luer lock 970 is engaged with the port assembly 900.
  • the port assembly 900 and/or the luer lock 970 may include ribs or slots to ensure proper alignment of the luer lock 970 and the port assembly 900 in the engaged position.
  • One result of the variant port assembly 900/luer lock 970 combination would be to limit the passage of the contents of the lumen 922 into the administration set, thereby further limiting the bolus effect, although potentially with some attendant loss of dose recovery.
  • Still further embodiments of a port assembly according to the present disclosure, including a slit septum and perforator, are illustrated in the embodiments of Figs. 29-45.
  • Figs. 29-33 illustrate embodiments of a port assembly including positive displacement having a single lumen that extends between the ends of the perforator, but using air as the working fluid.
  • the embodiments of Figs. 34-45 illustrate embodiments of a port assembly including positive displacement and a multi-lumen perforator, thereby reinforcing how elements of the various embodiments discussed separately above may be combined according to still other embodiments.
  • the port assembly 1000 includes a housing 1002 with an opening 1004 and a bore 1006 therethrough.
  • the opening 1004 is disposed at a first end 1008 of the housing 1002.
  • An overmolded slit septum 1010 is disposed in the opening 1004 to control access through the opening 1004, and depends into the bore 1006.
  • the cross-section of the bore 1006 may narrow slightly at the opening 1004 to define a rim 1012 with a shoulder 1014, against which the slit septum 1010 is disposed.
  • the slit septum 1010 shaped as illustrated may be referred to as an inwardly-concave overmolded slit septum, as has been discussed in detail above.
  • the slit septum 1010 may be molded as a single structure (i.e., integrally) with a sleeve 1016 having first and second ends 1018, 1020.
  • the sleeve 1016 has an inner surface 1022, and an inwardly depending ring 1024 disposed at the second end 1020 of the sleeve 1016.
  • the structure and function of the ring 1024 will be discussed in detail below.
  • a base 1030 is joined to the housing 1002 at the opposite end 1032 of the housing 1002 from the opening 1004, and has a membrane 1034 attached thereto by molding the membrane 1034 thereon.
  • a resilient member 1036 is formed as a single structure with the membrane 1034, and depends along the bore 1006 from the end 1032 of the housing 1002 in the direction of the end 1008.
  • the resilient member 1036 may also be formed separately from the membrane 1034, such that the only the membrane 1034 is molded on the base 1030.
  • the resilient member 1036 has an internal bore 1038 with a first and second ends 1040, 1042.
  • the resilient member 1036 may have one or more grooves on or in an external surface 1044 to appear star- shaped in cross-section, such as the embodiment illustrated in Fig. 2.
  • the port assembly 1000 also includes a perforator 1050 having a first end 1052 abutting the slit septum 1010 and a second end 1054 aligned with the membrane 1034.
  • the first end 1052 of the perforator 1050 may have a surface 1056 that has a curvature similar to that of a surface 1058 of the slit septum 1010.
  • the surface 1056 is held abutting against the surface 1058 according to the biasing provided by the resilient member 1036, the perforator 1050 being received within the bore 1038 of the resilient member 1036.
  • the cross-section of the region of the perforator 1050 that mates with the first end 1040 of the bore 1038 of the resilient member 1036 may be slightly larger than the cross-section of the bore 1038 at this point.
  • the first end 1052 of the perforator 1050 may have central lumen 1060 and a plurality of passages 1062, defined by grooves or channels, disposed about the circumference of the first end 1052.
  • the passages 1062 are provided to permit passage of fluids between the lumen 1060 to provide the positive displacement referred to above. While four passages 1062 may be used as illustrated in Fig. 22, other numbers of passages may be used instead.
  • the perforator 1050 also includes one or more flanges 1064 disposed at or near the midsection of the perforator 1050, and a hollow tube or cannula 1066 that depends from the flanges 1064 to the second end 1054 of the perforator 1050.
  • the flanges 1064 may have a gasket 1068 that is overmolded onto the flanges 1064, the gasket 1068 having an outwardly depending ring 1070 that abuts an internal surface 1072 of the bore 1006 of the housing 1002 to provide a fluid-tight seal therebetween.
  • this fluid-tight seal should limit the passage of both gases and liquids across the seal.
  • the cannula 1066 ends in a pointed profile 1074, with at least one aperture 1076 formed therein.
  • the operation of the port assembly 1000 is now discussed with reference to Figs. 29-32.
  • the operation of the port assembly 1000 will be discussed in conjunction with the insertion and removal of a luer tip 1080.
  • the luer tip 1080 is formed as part of a luer lock, with mating threads of the housing 1002 and the luer lock cooperating to secure the luer tip 1080 to the port assembly 1000, the luer tip 1080 could just as easily be a slip luer instead.
  • the luer tip 1080 is inserted into the port assembly 1000 and passed through the slit septum 1010, causing the slit septum 1010 to deflect.
  • the luer tip 1080 abuts the first end 1052 of the perforator 1050, advancing the perforator 1050 in the direction of the membrane 1034 against the biasing of the resilient member 1036.
  • the pointed profile 1074 of the perforator 1050 punctures the membrane 1034 and passes into the membrane 1034, but as illustrated the aperture 1076 has not yet passed through the membrane 1034.
  • a fluid path exists between the perforator 1050 and a space (or reservoir) 1090 that opens between the perforator 1050 and the inner surface 1072 of the housing 1002.
  • the opening space 1090 is believed to create a vacuum, which pulls fluid into the space 1090 to fill it. Because the membrane 1034 has not yet been punctured to the point to permit fluid to pass through the membrane 1034 into the aperture 1076, fluid is not drawn from outside the port assembly 1000. Further, while some material may be pulled through the luer tip 1080, it is believed that the fluid will mainly be drawn from the bore 1038 of the resilient member 1036, which is filled with air at the time of manufacture.
  • the volume of fluid within the space 1090 should be greater than a 1:1 ratio relative to the volume of the lumen 1060 to ensure adequate flushing of the lumen 1060. For example, it is believed that ratios of 3:1 or better for the volume within the space 1090 relative to the volume of the lumen 1060 should be attained. Of course, even higher ratios are believed to provide even better flushing results, and one may attempt to maximize ratio for a given configuration. For example, computational fluid dynamics indicates that an 8:1 ratio will leave a projected drug residue of approximately 0.013 percent in the lumen 1060 after withdrawal of the luer tip.
  • the cross-section of the lumen 1060 may be reduced to reduce the volume of the lumen relative to the volume of the space 1090, and thereby increase the ratio.
  • Flow resistance is relevant not only because the lumen 1060 may be used when injecting medication and other fluids through the port assembly 1000, but also because fluid may be aspirated from the container through the port assembly 1000 as well.
  • the lumen 1060 may have a cross-sectional area that is double the cross-sectional area of an 18-gauge needle.
  • the air from the bore 1038 passes into the aperture 1076, into the lumen 1060, and through the passages 1062.
  • the air would then pass between the first end 1052 of the perforator 1050 and the sleeve 1016.
  • the ring 1024 is spaced from the first end 1052 of the perforator 1050, so that fluid may pass around the ring 1024 and into the space 1090.
  • the first end 1052 of the perforator 1050 may have grooves or channels formed therein to facilitate fluid flow around the perforator 1050.
  • the flow of fluid in the space 1090 past the flanges 1064 should be limited because of the cooperation of the gasket 1068 and the inner surface 1072 of the housing 1002.
  • FIG. 31 Further movement, as illustrated in Fig. 31, causes the second end 1054 of the perforator 1050 to advance past the membrane 1034, at which time force may be applied to inject medication or other material into the container through the luer tip 1080.
  • the first end 1052 of the perforator 1050 has come in contact with the ring 1024, such that the space 1090 has been sealed off.
  • the medication or other material thus will bypass the space 1090.
  • the first end 1052 of the perforator 1050 may include a head 1092 of larger cross-section, permitting a more positive seal to be formed between the perforator 1050 and the ring 1024.
  • the movement of the perforator 1050 reverses direction, passing from a fully extended state illustrated in Fig. 31 to a standby state illustrated in Fig. 29.
  • the movement of the flanges 1064 and the sealing provided between the gasket 1068 and the inner surface 1072 of the housing 1002 causes the air in the space 1090 to flow along the flow path described above, and into the lumen 1060.
  • any medication in or about the port assembly 1000 will experience an automatic flush as the luer tip 1050 is withdrawn, which is believed to reduce the amount of medication in the lumen 1060 and in or about the port assembly 1000.
  • the reduction in medication in or about the port assembly 1000 is believed to increase the dose recovery for the port assembly, or to reduce the risk of bolus infusion.
  • a port assembly 1100 according to a variant of the port assembly 1000 is illustrated in Fig. 33.
  • the differences between the port assembly 1000 and the port assembly 1100 are located at the first end of the perforator. Given the similarity of the two embodiments, similar structures have been numbered similarly with the inclusion of a prime for the embodiment illustrated in Fig. 33.
  • the first end 1052 of the perforator 1050 included a plurality of passages 1064 formed in the surface 1056
  • the perforator 1050' lacks such passages 1064.
  • the perforator 1050' includes one or more passages 1102 formed along a side surface 1104 of the head 1092' of the perforator 1050' facing the sleeve 1016'. These passages 1102 have a first end 1106 in fluid communication with the lumen 1060' of the perforator 1050', and a second end 1108 in fluid communication outside the perforator 1050'.
  • the surface 1056' may more closely mate with the inner surface 1058' of the slit septum 1010', without concern for discontinuities or sharp edges that may occur during manufacturing of the passages 1064 present in the perforator 1050.
  • air is still permitted to pass through the lumen 1060' into the passages 1102 as the luer tip is inserted into the port assembly 1100, or to pass through the passages 1102 into the lumen 1060' as the luer tip is removed from the port assembly 1100.
  • the operation of the port assembly 1100 is very similar to the operation of the port assembly 1000, while the placement of the passages 1102 may permit a smoother surface 1056' to be manufactured.
  • Figs. 34-45 are similar to the embodiments of Figs. 29-33 in that a flushing is provided.
  • one or more secondary lumens may be incorporated, in association with one or more valves, into the perforator.
  • the secondary lumens may be disposed inside or on the outside of the perforator, and may be combined with oneway or multi- state valves.
  • the port assembly 1120 includes a housing 1122 with an opening 1124 and a bore 1126 therethrough.
  • the opening 1124 is disposed at a first end 1128 of the housing 1022.
  • An inwardly- concave overmolded slit septum 1130 is disposed in the opening 1124 to control access through the opening 1124.
  • the slit septum 1130 may be molded as a single structure (i.e., integrally) with a sleeve 1132 having first and second ends 1134, 1136 and an inner surface 1138.
  • a base 1140 is joined to the housing 1122 at the opposite end 1142 of the housing 1122 from the opening 1124, and has a membrane 1144 molded thereon.
  • a resilient member 1146 is formed as a single structure with the membrane 1144, and depends along the bore 1126 from the end 1142 of the housing 1122 in the direction of the end 1128.
  • the resilient member 1146 has an internal bore 1148 with a first and second ends 1150, 1152.
  • the port assembly 1100 also includes a perforator 1160 having a first end 1162 abutting the slit septum 1130 and a second end 1164 aligned with the membrane 1144.
  • the first end 1162 of the perforator 1160 may have a surface 1166 that has a curvature similar to that of a surface 1168 of the slit septum 1130. The surface 1166 is held abutting against the surface 1168 according to the biasing provided by the resilient member 1146, the perforator 1160 being received within the bore 1148 of the resilient member 1146.
  • the cross-section of the region of the perforator 1160 that mates with the first end 1150 of the bore 1148 of the resilient member 1146 may be slightly larger than the cross-section of the bore 1148 at this point.
  • the perforator 1160 does not have passages at the first end 1162. Quite the contrary, the perforator 1160 has a seal 1170 formed on the first end 1162.
  • the perforator 1160 has a main, or principal, lumen 1172 having a first end 1174 about which the seal 1170 is disposed.
  • the seal 1170 is intended to form a fluid-tight seal with a luer tip 1180 when the luer tip 1180 is inserted into the port assembly 1100 through the slit septum 1130 and abuts the first end 1162 of the perforator 1160. It will be recognized that this seal could alternatively be formed (by molding, for example) on the end of the luer tip 1180.
  • the perforator 1160 includes one or more flanges 1190 and a hollow tube or cannula 1192 that depends from the flanges 1190 to the second end 1164 of the perforator 1160.
  • the flanges 1190 may have a gasket 1194 that is overmolded onto the flanges 1190, the gasket 1194 having an outwardly depending ring 1196 that abuts an internal surface 1198 of the bore 1126 of the housing 1122 to provide a fluid-tight seal therebetween.
  • the cannula 1192 ends in a pointed profile 1200, with at least one aperture 1202 formed therein that is in fluid communication with a second end 1204 of the main lumen 1172.
  • the perforator 1160 includes one or more secondary lumens 1210 formed at least partially on an outer surface 1212 of the perforator 1160. As illustrated, the perforator 1160 illustrated in Figs. 34 and 35 includes a single secondary lumen 1210. The secondary lumen 1210 depends along the perforator 1160 between the second end 1164 of the perforator 1160 and the one or more flanges 1190 depending outwardly from the perforator 1160.
  • the secondary lumen 1210 has a first section 1214 that is parallel to a longitudinal axis of the perforator (and hence parallel to the main lumen 1172) and a second section 1216 that is at an angle to the first section 1214 with an opening 1218; as illustrated, the first and second sections 1214, 1216 are orthogonal to each other, although this should not be construed as limiting the lumen 1210 to only such a configuration.
  • a valve 1220 is disposed over the opening 1218.
  • the valve 1220 may comprise a flap of material that is molded over the opening 1218 at the same time that the gasket 1194 is molded to the perforator 1160. The flap may be separated from the remainder of the material during a post-molding operation, so as to define the valve 1220.
  • the valve 1220 is a one-way valve, permitting fluid to flow through the secondary lumen 1210 in the direction of the first end 1128 of the housing 1122 and limiting flow of fluid through the secondary lumen 1210 in the direction of the second end 1142 of the housing 1122.
  • a space 1230 opens between the perforator 1160 and the inner surface 1198 of the housing 1122, as illustrated in Fig. 35.
  • the space 1230 is believed to create a vacuum, which pulls fluid into the space 1230. Because the luer tip 1180 is sealed so as to limit fluid passage through other than the main lumen 1172, it is believed that the fluid drawn into the space 1230 will come from the container associated with the port assembly 1100, through the secondary lumen 1210 and past the valve 1220.
  • the flushing of the main lumen 1172 and the adjacent volume within the container will be enhanced (i.e., the injectable fluid cleared from the lumen 1172 will be further diluted) when the luer tip 1180 is withdrawn and the fluid is expelled from the space 1230. It will also be recognized that the absence of the grooves or channels present in other embodiments and the presence of the seal 1170 will limit the number of irregularities on the surface 1166 that may otherwise result from manufacturing and may cause damage to the slit septum 1130.
  • FIG. 36-45 illustrate a number of variants that would have a structure similar to the port assembly 1120 illustrated in Figs. 34 and 35, differing only as to the structure of the perforator. In particular, the differences relate to the shape, manufacture and operation of the valve associated with the secondary lumen. These variant port assemblies would operate similar to the port assembly 1120, as will be discussed in detail relative to the embodiment of Figs. 36-39, and will be recognized by extension to the further variants of perforator illustrated in Figs. 40-42 and 43-45. [00168] Figs. 36 and 37 illustrate a perforator 1250, before and after the second step of a two-shot molding process. As seen in Fig.
  • the perforator 1250 has a first end 1252 and a second end 1254. Disposed between the first and second ends 1252, 1254 are a pair of flanges 1256, although a single flange could have been included instead.
  • a cannula 1258 is connected to the flanges 1256 at a first end 1260 and has pointed profile 1262 as a second end 1264.
  • Two apertures 1270, 1272 are formed at or near the first end 1252 of the perforator 1250.
  • the two apertures 1270, 1272 are each associated with a separate lumen 1274, 1276, as seen in Figs. 38 and 39.
  • the two lumens 1274, 1276 are both enclosed in the cannula 1258.
  • the apertures 1270 are spaced from each other, with the first aperture 1270 being disposed at the end 1252 of the perforator 1250, while the second aperture 1272 is disposed adjacent the flanges 1256.
  • a second step of a two-shot molding process has been performed to define additional features of the perforator 1250.
  • two gaskets 1280, 1282 have been formed.
  • the first gasket 1280 is disposed at the first end 1252 of the perforator 1250 about the first aperture 1270.
  • the gasket 1280 has a function similar to that of the seal 1170, described above: to seal a luer tip to the perforator 1250 to limit passage of fluid through other than the main lumen 1274.
  • the second gasket 1282 is formed about the flanges 1256, and has an outwardly depending ring 1284 formed therewith, which ring 1284 will cooperate with an inner surface of a bore of a port assembly to form a fluid-tight seal therewith. Also formed with the gaskets 1280, 1282 is a valve 1286.
  • valve 1286 is a one-way valve associated with the second aperture 1272.
  • the valve 1286 is also associated with the secondary lumen 1276.
  • the valve 1286 which may be referred to as a flap (or flapper) valve, is formed by separating the valve 1286 from the remainder of the molding along three of four sides of a rectangle, by cutting the molding along these three sides in a post- molding operation, for example.
  • the fourth side forms a living hinge 1288, permitting the valve 1286 to pivot about the fourth side to open and close.
  • the living hinge 1288 may be designed to be prebiased in the direction of a closed state, and to bias the valve 1286 to the closed state even in the absence of a separate biasing mechanism.
  • the perforator 1250 would be incorporated into a port assembly 1300 according to the present disclosure as illustrated in Figs. 38 and 39.
  • the port assembly 1300 includes a housing 1302 with an opening 1304 and a bore 1306 therethrough.
  • the opening 1304 is disposed at a first end 1308 of the housing 1302.
  • An overmolded slit septum 1310 is disposed in the opening 1304 to control access through the opening 1304, and depends into the bore 1306.
  • the cross-section of the bore 1306 may narrow slightly at the opening 1304 to define a rim 1312 with a shoulder 1314, against which the slit septum 1310 is disposed.
  • the slit septum 1310 shaped as illustrated may be referred to as an inwardly-concave overmolded slit septum, as has been discussed in detail above.
  • a base 1320 is joined to the housing 1302 at the opposite end 1322 of the housing 1302 from the opening 1304, and has a membrane 1324 attached thereto.
  • a resilient member 1326 is formed as a single structure with the membrane 1324, and depends along the bore 1306 from the end 1322 of the housing 1302 in the direction of the end 1308.
  • the resilient member 1326 has an internal bore 1328 with a first and second ends 1330, 1332.
  • the perforator 1250 is fitted into the bore 1328 of the resilient member 1326.
  • a luer tip 1340 is inserted into the port assembly 1300 and through the septum 1310, advancing the perforator 1250 in the direction of the second end 1322 of the housing 1302.
  • a space 1342 opens between the perforator 1250 and an inner surface 1344 of the housing 1302, creating a vacuum that pulls fluid into the space 1342.
  • fluid is drawn through the lumen 1276 past the valve 1286, which is open as illustrated in Fig. 39.
  • the luer tip 1340 is withdrawn, transitioning between a fully extended state illustrated in Fig. 39 and a standby state illustrated in Fig.
  • the perforator 1250 reverses direction.
  • the luer tip 1340 will separate from the first end 1252 of the perforator 1250 and a gap will develop as explained above.
  • the fluid is urged out of the space 1342 and passes through the gap between the luer tip 1340 and the first end of the perforator 1250 and into the lumen 1274.
  • any medication in or about the port assembly 1300 will experience an automatic flush as the luer tip 1340 is withdrawn, leading to a reduction in the amount of medication in the lumen 1274 and in or about the port assembly 1300.
  • Figs. 40-42 and 43-45 illustrate two additional perforators that may be substituted for the perforator 1250 in the port assembly 1300. As such, the discussion will concentrate on the perforators, rather than repeat the discussion regarding their placement and operation within the port assembly 1300. It is not believed that any modifications would be required to the other elements of the port assembly 1300 to utilize the perforators in Figs. 40-45 in substitution for the perforator 1250.
  • Figs. 40-42 illustrate a first alternate perforator 1350 having a first end 1352 and a second end 1354. Disposed between the first and second ends 1352, 1354 are a pair of flanges 1356, although a single flange could have been included instead.
  • a cannula 1358 is connected to the flanges 1356 at a first end 1360 and has pointed profile 1362 as a second end 1364.
  • Two apertures 1370, 1372 are formed at or near the first end 1352 of the perforator 1350.
  • the two apertures 1370, 1372 are each associated with a separate lumen 1374, 1376, as seen in Fig. 42.
  • the apertures 1370, 1372 are spaced from each other, with the first aperture 1370 being disposed at the end 1352 of the perforator 1350, while the second aperture 1372 is disposed adjacent the flanges 1356.
  • a third aperture 1378 may also be provided at the first end 1352 of the perforator 1350 to facilitate the molding of the perforator 1350.
  • a second step of a two-shot molding process has been performed to define additional features of the perforator 1350.
  • two gaskets 1380, 1382 have been formed.
  • the first gasket 1380 is disposed at the first end 1352 of the perforator 1350 about the first aperture 1370 to seal a luer tip to the perforator 1350.
  • the second gasket 1382 is formed about the flanges 1356, and has an outwardly depending ring 1384 formed therewith to cooperate with an inner surface of a bore of a port assembly to form a fluid-tight seal therewith.
  • a valve 1386 is also formed with the gaskets 1380, 1382.
  • valve 1386 is a one-way valve associated with the second aperture 1372.
  • the valve 1386 is also associated with the secondary lumen 1376.
  • the valve 1386 which may be referred to as a flap valve, is formed by separating the valve 1386 from the surface of the flange 1356. This may be performed by advancing a cutting blade parallel to the surface of the flange 1356 to separate the valve 1386 from the flange in a post-molding operation.
  • a living hinge 1388 is thus formed, permitting the valve 1386 to pivot about the hinge 1388 to open and close and to be biased toward a closed state even in the absence of a separate biasing mechanism.
  • FIGs. 43-45 illustrate a second alternate perforator 1400 having a first end 1402 and a second end 1404. Disposed between the first and second ends 1402, 1404 are a pair of flanges 1406, although a single flange could have been included instead. A cannula 1408 is connected to the flanges 1406 at a first end 1410 and has pointed profile 1412 as a second end 1414.
  • Two apertures 1420, 1422 are formed at or near the first end 1402 of the perforator 1400.
  • the two apertures 1420, 1422 are each associated with a separate lumen, one of which (1424) is illustrated in cross-section in Fig. 45.
  • the apertures 1420, 1422 are spaced from each other, with the first aperture 1420 being disposed at the end 1402 of the perforator 1400, while the second aperture 1422 is disposed adjacent the flanges 1406.
  • a third aperture 1428 may also be provided at the first end 1402 of the perforator 1400 to facilitate the molding of the perforator 1400, as was the case in regard to the perforator 1350.
  • a second step of a two-shot molding process has been performed to define additional features of the perforator 1400.
  • two gaskets 1430, 1432 have been formed.
  • the first gasket 1430 is disposed at the first end 1402 of the perforator 1400 about the first aperture 1420 to seal a luer tip to the perforator 1400.
  • the second gasket 1432 is formed about the flanges 1406, and has an outwardly depending ring 1434 formed therewith to cooperate with an inner surface of a bore of a port assembly to form a fluid-tight seal therewith.
  • a valve 1440 is also formed with the gaskets 1430, 1432.
  • the valve 1440 is a slit valve that operates to open and close according to different differential pressures that exist across the valve.
  • the valve 1440 is formed in a groove 1442 (as seen in Figs. 43 and 45) that is in communication with the aperture 1422.
  • the groove 1442 is covered in the second step of the two-shot molding process with a wall 1444, the thickness of which may be exaggerated in Fig. 45 to facilitate illustration of the elements of the valve 1440.
  • a cutting blade is advanced toward the longitudinal axis of the perforator 1400 in the direction of a wall 1446.
  • a pin may be disposed along the wall 1446 to define a passage 1448 in communication with the aperture 1422, and to cooperate with the cutting blade to form a slit 1450 in the wall 1444.
  • the differential pressures across the slit 1450 will cause the valve 1440 to open to permit fluid flow across the barrier defined by the wall 1446.
  • a neutral differential pressure will maintain the valve 1440 in a closed state. If the differential pressure of the fluid in the passage 1448 relative to the space beyond the wall 1446 exceeds a first cracking pressure, the slit 1450 will open and fluid will be permitted to flow through the slit 1450 past the wall 1444.
  • the slit will open and be permitted to flow through the slit 1450 into the passage 1448.
  • the second cracking pressure may set so that over a range of normal operating pressures, the valve 1440 acts essentially as a one-way valve, permitting fluid to flow from the passage 1448 through the slit 1450 while limiting fluid flow along the reverse path.
  • some degree of backflow through the valve 1440 may be permissible during flushing.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L’invention concerne un ensemble de port comprenant un boîtier muni d’un orifice et un trou au travers dudit, un septum fendu disposé dans le trou et servant à commander l’accès à l’orifice, une base jointe au boîtier et pourvue d’une membrane fixée au dit, un perforateur possédant une première extrémité venant en butée contre le septum fendu et une seconde extrémité alignée avec la membrane, et un élément résilient disposé entre le perforateur et la base. L’ensemble de port peut être utilisé dans un récipient pour fluide comportant un réceptacle destiné à contenir un fluide et au moins une conduite en communication avec le réceptacle. Ladite au moins une conduite peut être définie, au moins en partie, par l’ensemble de port.
EP20090791621 2008-08-19 2009-08-18 Ensemble de port à utiliser avec un connecteur sans aiguille Withdrawn EP2326385A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/194,137 US8062280B2 (en) 2008-08-19 2008-08-19 Port assembly for use with needleless connector
PCT/US2009/054185 WO2010022068A2 (fr) 2008-08-19 2009-08-18 Ensemble de port à utiliser avec un connecteur sans aiguille

Publications (1)

Publication Number Publication Date
EP2326385A2 true EP2326385A2 (fr) 2011-06-01

Family

ID=41381857

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20090791621 Withdrawn EP2326385A2 (fr) 2008-08-19 2009-08-18 Ensemble de port à utiliser avec un connecteur sans aiguille

Country Status (4)

Country Link
US (2) US8062280B2 (fr)
EP (1) EP2326385A2 (fr)
CA (1) CA2732838A1 (fr)
WO (1) WO2010022068A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6695817B1 (en) 2000-07-11 2004-02-24 Icu Medical, Inc. Medical valve with positive flow characteristics
JP2008518719A (ja) 2004-11-05 2008-06-05 アイシーユー メディカル インコーポレイテッド 医療用ソフトグリップ・コネクタ
US7473246B2 (en) * 2006-06-22 2009-01-06 Baxter International Inc. Medicant reconstitution container and system
US8414554B2 (en) 2008-05-14 2013-04-09 J & J Solutions, Inc. Systems and methods for safe medicament transport
US8172823B2 (en) * 2008-07-03 2012-05-08 Baxter International Inc. Port assembly for use with needleless connector
US8062280B2 (en) * 2008-08-19 2011-11-22 Baxter Healthcare S.A. Port assembly for use with needleless connector
US8454579B2 (en) 2009-03-25 2013-06-04 Icu Medical, Inc. Medical connector with automatic valves and volume regulator
US8394080B2 (en) * 2009-05-14 2013-03-12 Baxter International Inc. Needleless connector with slider
EP2353629A1 (fr) * 2010-02-08 2011-08-10 Fresenius Kabi Deutschland GmbH Connecteur pour récipient contenant un agent actif médical
USD644731S1 (en) 2010-03-23 2011-09-06 Icu Medical, Inc. Medical connector
US8758306B2 (en) 2010-05-17 2014-06-24 Icu Medical, Inc. Medical connectors and methods of use
AU2011258371B2 (en) 2010-05-27 2014-09-18 J&J Solutions, Inc. Closed fluid transfer system
CN102553027B (zh) * 2010-12-22 2015-06-03 潘秀凤 无正负压免针式注射连接器
US20120265163A1 (en) * 2011-04-14 2012-10-18 Marc Bunjiun Cheng Coupling system to transfer material between containers
CN103608057B (zh) * 2011-04-18 2016-10-12 皮博士研究所有限责任公司 具有封闭件的针及方法
EP2804645B1 (fr) * 2012-01-17 2017-04-12 Dr. Py Institute, LLC Flacon à doses multiples et procédé
ITBS20120034A1 (it) * 2012-03-09 2013-09-10 Guala Pack Spa Cannuccia per imballi flessibili, in particolare per liquidi per nutrizione enterale
JP6223959B2 (ja) 2012-03-12 2017-11-01 テルモ株式会社 血液流路切換装置及び血液バッグシステム
CN104507529B (zh) 2012-04-17 2017-11-17 皮博士研究所有限责任公司 自封闭连接器
BR112014027280A2 (pt) 2012-05-01 2017-06-27 Py Dr Inst Llc dispositivo para conexão ou enchimento e método
US10351271B2 (en) 2012-05-01 2019-07-16 Dr. Py Institute Llc Device for connecting or filling and method
BR102012015897A2 (pt) * 2012-06-27 2015-04-14 Hsiu Feng Pan Conector de injeção de medicamento livre de agulha sem a ocorrência de pressão não positiva e não negativa
JP6243354B2 (ja) * 2012-12-28 2017-12-06 株式会社コーセー リフィル容器用注出構造
US20140230368A1 (en) * 2013-02-21 2014-08-21 Medrad, Inc. Bottle spike with wide-bore introducer
EP2826519A1 (fr) * 2013-07-15 2015-01-21 Becton Dickinson France Adaptateur pour un dispositif d'administration de médicament et procédé pour monter ledit adaptateur sur celui-ci
AU2014295975B2 (en) 2013-08-02 2018-08-02 J&J SOLUTIONS, INC. d.b.a CORVIDA MEDICAL Compounding systems and methods for safe medicament transport
DE102013220073A1 (de) * 2013-10-02 2015-04-16 Parker Hannifin Manufacturing Germany GmbH & Co. KG Verbindungselement
WO2015088862A1 (fr) 2013-12-11 2015-06-18 Icu Medical, Inc. Clapet antiretour
US9895525B2 (en) 2014-01-21 2018-02-20 Becton, Dickinson And Company Ported catheter adapter with integrated septum actuator retention
USD793551S1 (en) 2014-12-03 2017-08-01 Icu Medical, Inc. Fluid manifold
USD786427S1 (en) 2014-12-03 2017-05-09 Icu Medical, Inc. Fluid manifold
ITUB20151860A1 (it) * 2015-07-02 2017-01-02 Gvs Spa Connettore medicale perfezionato
WO2017049107A1 (fr) 2015-09-17 2017-03-23 J&J SOLUTIONS, INC. d/b/a Corvida Medical Ensemble flacon de médicament
EP3362114B1 (fr) 2015-10-13 2024-03-27 Cormed Ltd Équipement de compoundage automatisé pour système de transfert de fluide fermé
WO2017095818A1 (fr) 2015-12-04 2017-06-08 Carefusion 303, Inc. Collecteur pour mélangeur automatique de médicament
CA3050846A1 (fr) 2016-01-19 2017-07-27 Daniel Py Connecteurs a usage unique
JP7172329B2 (ja) * 2018-09-18 2022-11-16 大日本印刷株式会社 充填用針及びそれを備えた充填装置、軟質容器
TWI687245B (zh) * 2019-09-17 2020-03-11 慈濟學校財團法人慈濟科技大學 輸液套管
EP4308214A1 (fr) * 2021-03-15 2024-01-24 Centre for Commercialization of Regenerative Medicine Raccord aseptique avec sas d'air jetable
US20230000407A1 (en) * 2021-07-02 2023-01-05 Becton, Dickinson And Company Instrument Advancement Device Having a Septum
NL2028804B1 (en) * 2021-07-22 2023-01-27 Inreda Diabetic B V Transport element for transporting a substance contained in a reservoir, infusion set comprising such a transport element, system for regulating the concentration of glucose in the blood of a person comprising such an infusion set, combination of a reservoir and such a transport element, infusion set or system, and method of at least fluidly connecting such a transport element to a reservoir

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3368560A (en) * 1965-10-07 1968-02-13 Theodore H. Gewecke Outlet fitting for plastic parenteral solution container
US3509879A (en) * 1967-11-24 1970-05-05 American Hospital Supply Corp Parenteral liquid container having frangible part structure
US3915212A (en) * 1973-12-10 1975-10-28 Abbott Lab Flexible medical fluid container having a combined fill and administration port and reinforced hanger
US3977555A (en) 1974-05-07 1976-08-31 Pharmaco, Inc. Protective safety cap for medicament vial
US4294247A (en) * 1977-07-25 1981-10-13 Baxter Travenol Laboratories, Inc. Frangible, resealable closure for a flexible tube
US4181140A (en) * 1978-02-10 1980-01-01 Baxter Travenol Laboratories, Inc. Frangible resealable closure for a flexible tube having hold open means
US4187893A (en) * 1978-07-19 1980-02-12 Abbott Laboratories Combined additive and administration port for a container
US4270534A (en) * 1979-08-08 1981-06-02 Baxter Travenol Laboratories, Inc. Frangible valve assembly for blood bags and the like
US4340049A (en) * 1979-10-18 1982-07-20 Baxter Travenol Laboratories, Inc. Breakaway valve
US4386622A (en) * 1979-10-18 1983-06-07 Baxter Travenol Laboratories, Inc. Breakaway valve
US4435179A (en) * 1981-11-09 1984-03-06 Biotest-Serum-Institut Gmbh Blood bags with interconnecting system
US4458733A (en) * 1982-04-06 1984-07-10 Baxter Travenol Laboratories, Inc. Mixing apparatus
US4410321A (en) * 1982-04-06 1983-10-18 Baxter Travenol Laboratories, Inc. Closed drug delivery system
US4479989A (en) * 1982-12-02 1984-10-30 Cutter Laboratories, Inc. Flexible container material
US4484351A (en) 1983-05-23 1984-11-20 Union Carbide Corporation Non-glass chemical container
JPS607833U (ja) * 1983-06-27 1985-01-19 テルモ株式会社 血液バツグ装置
US4507114A (en) * 1983-10-21 1985-03-26 Baxter Travenol Laboratories, Inc. Multiple chamber container having leak detection compartment
US4589879A (en) 1983-11-04 1986-05-20 Baxter Travenol Laboratories, Inc. Cannula assembly having closed, pressure-removable piercing tip
SE442264B (sv) 1983-12-23 1985-12-16 Bengt Gustavsson Ampull
US4583971A (en) * 1984-02-10 1986-04-22 Travenol European Research And Development Centre (Teradec) Closed drug delivery system
DE3407820A1 (de) * 1984-03-02 1985-11-07 Siemens AG, 1000 Berlin und 8000 München Verfahren zur herstellung eines fasertapers mit brechender linse
US4637934A (en) * 1984-04-12 1987-01-20 Baxter Travenol Laboratories, Inc. Liquid container with integral opening apparatus
US4722727A (en) * 1984-07-18 1988-02-02 Abbott Laboratories Flexible container
US4586928A (en) * 1984-10-09 1986-05-06 Miles Laboratories, Inc. Pivoting frangible valve for plastic bags
CA2006582A1 (fr) * 1988-12-27 1990-06-27 Gabriel Meyer Flacon de stockage et de transfert concu pour stocker deux composants dune substance medicamenteuse
US5304163A (en) * 1990-01-29 1994-04-19 Baxter International Inc. Integral reconstitution device
US5006114A (en) 1990-04-20 1991-04-09 Rogers Bobby E Medical valve assembly
US5065783A (en) 1990-09-20 1991-11-19 George Braddock Ogle, II Valve with self-sealing internal cannula
US5122123A (en) * 1991-01-30 1992-06-16 Vaillancourt Vincent L Closed system connector assembly
US5308347A (en) * 1991-09-18 1994-05-03 Fujisawa Pharmaceutical Co., Ltd. Transfusion device
US5694686A (en) * 1991-12-18 1997-12-09 Icu Medical, Inc. Method for assembling a medical valve
CA2588574A1 (fr) 1991-12-18 1993-06-24 Icu Medical, Inc. Valve medicale
JPH05212090A (ja) * 1992-02-04 1993-08-24 Material Eng Tech Lab Inc 輸液容器
US5330464A (en) * 1992-03-11 1994-07-19 Baxter International Inc. Reliable breakable closure mechanism
US5810398A (en) * 1992-10-02 1998-09-22 Pall Corporation Fluid delivery systems and methods and assemblies for making connections
US5391150A (en) 1992-12-28 1995-02-21 Richmond; Frank IV bag with needleless connector ports
US5269771A (en) * 1993-02-24 1993-12-14 Thomas Medical Products, Inc. Needleless introducer with hemostatic valve
US5334180A (en) * 1993-04-01 1994-08-02 Abbott Laboratories Sterile formed, filled and sealed flexible container
US5514123A (en) * 1993-04-01 1996-05-07 Abbott Laboratories Sterile formed, filled and sealed flexible container
US20050124942A1 (en) 1996-12-18 2005-06-09 Richmond Frank M. Spikeless connection and drip chamber with valve
US5540674A (en) * 1993-09-28 1996-07-30 Abbott Laboratories Solution container with dual use access port
US5785693A (en) 1993-11-26 1998-07-28 Haining; Michael L. Medical connector
AU2945495A (en) * 1994-06-24 1996-01-19 Icu Medical, Inc. Fluid transfer device and method of use
US5782816A (en) 1995-09-07 1998-07-21 David R. Kipp Bi-directional valve and method of using same
US5738663A (en) * 1995-12-15 1998-04-14 Icu Medical, Inc. Medical valve with fluid escape space
US5700248A (en) * 1995-12-15 1997-12-23 Icu Medical, Inc. Medical valve with tire seal
FR2749371B1 (fr) 1996-06-03 1998-08-14 Staubli Sa Ets Raccord rapide de securite pour la jonction amovible des canalisations
US7387216B1 (en) 1996-07-17 2008-06-17 Smith James C Closure device for containers
US20020024036A1 (en) * 1996-08-01 2002-02-28 Rohrbough John D. Indwelling catheter valve
US5730418A (en) 1996-09-30 1998-03-24 The Kipp Group Minimum fluid displacement medical connector
US6883778B1 (en) * 1996-11-18 2005-04-26 Nypro Inc. Apparatus for reducing fluid drawback through a medical valve
US6245048B1 (en) 1996-12-16 2001-06-12 Icu Medical, Inc. Medical valve with positive flow characteristics
CN1768871A (zh) * 1996-12-16 2006-05-10 Icu医学有限公司 正向流动阀
US5931829A (en) * 1997-01-21 1999-08-03 Vasca, Inc. Methods and systems for establishing vascular access
DE19717765C1 (de) 1997-04-26 1999-02-25 Fresenius Ag Steriler Konnektor und Folienbeutel mit einem sterilen Konnektor
US6050978A (en) * 1997-05-09 2000-04-18 Becton Dickinson And Company Needleless valve connector
EP1716885A3 (fr) 1997-05-09 2006-11-15 Pall Corporation Ensembles de connecteur, systèmes de fluide et méthodes pour faire une connection
SE512489C2 (sv) * 1997-07-14 2000-03-27 Arom Pak Ab Aseptisk anslutningsanordning
US6029946A (en) * 1997-09-15 2000-02-29 Tiva Medical Inc. Needleless valve
US20040122414A9 (en) 1997-09-22 2004-06-24 Hurst William S. Contoured tubing closure
US6491679B1 (en) 1997-10-20 2002-12-10 Rodney Okamoto System for infusing intravenous nutrition solutions
US5902298A (en) * 1997-11-07 1999-05-11 Bracco Research Usa Medicament container stopper with integral spike access means
DE29800107U1 (de) 1998-01-07 1998-03-05 Braun Melsungen Ag Schlauchkupplung für ein medizinisches Überleitungssystem
US6681946B1 (en) * 1998-02-26 2004-01-27 Becton, Dickinson And Company Resealable medical transfer set
US6132413A (en) * 1998-03-06 2000-10-17 Baxter International Inc. Breakable cannula assemblies and methods for manipulating them
US6179821B1 (en) * 1998-06-18 2001-01-30 Glenn A. Caspary Membrane port for a container
US7425209B2 (en) * 1998-09-15 2008-09-16 Baxter International Inc. Sliding reconstitution device for a diluent container
US7074216B2 (en) * 1998-09-15 2006-07-11 Baxter International Inc. Sliding reconstitution device for a diluent container
US6113583A (en) * 1998-09-15 2000-09-05 Baxter International Inc. Vial connecting device for a sliding reconstitution device for a diluent container
AR021220A1 (es) * 1998-09-15 2002-07-03 Baxter Int DISPOSITIVO DE CONEXIoN PARA ESTABLECER UNA COMUNICACIoN FLUíDA ENTRE UN PRIMER RECIPIENTE Y UN SEGUNDO RECIPIENTE.
US6726672B1 (en) * 1998-09-28 2004-04-27 Icu Medical, Inc. Intravenous drug access system
US6113068A (en) * 1998-10-05 2000-09-05 Rymed Technologies Swabbable needleless injection port system having low reflux
US6280431B1 (en) * 1998-10-23 2001-08-28 Abbott Laboratories Sterile formed, filled and sealed flexible container and draining administration port therefor
US6126618A (en) * 1999-01-14 2000-10-03 Baxter International Inc. Apparatus for obtaining liquid samples
US6585229B2 (en) * 1999-01-27 2003-07-01 Nypro Inc. Medical nozzle securing apparatus
US6156025A (en) 1999-06-17 2000-12-05 Bracco Research Usa Inc. Twist valve
FR2800713B1 (fr) 1999-11-05 2002-01-04 Biodome Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif
US6755391B2 (en) 2000-10-23 2004-06-29 Nypro Inc. Anti-drawback medical valve
FR2819418B1 (fr) 2001-01-17 2003-03-14 Technoflex Sa Set de transfert notamment pour l'administration d'un melange de liquides a des fins medicales
US6745998B2 (en) * 2001-08-10 2004-06-08 Alaris Medical Systems, Inc. Valved male luer
US7396348B2 (en) * 2001-08-22 2008-07-08 Nypro Inc. Medical valve with expandable member
US7004934B2 (en) * 2001-09-06 2006-02-28 Vaillancourt Vincent L Closed system connector assembly
US7037302B2 (en) * 2001-09-07 2006-05-02 Patricia B. Vaillancourt, legal representative Positive flow needleless connector
US6869426B2 (en) * 2001-11-13 2005-03-22 Nypro Inc. Anti-drawback medical valve
US6802490B2 (en) * 2001-11-29 2004-10-12 Alaris Medical Systems, Inc. Needle free medical connector with expanded valve mechanism and method of fluid flow control
US6651956B2 (en) 2002-01-31 2003-11-25 Halkey-Roberts Corporation Slit-type swabable valve
FR2836129B1 (fr) 2002-02-20 2004-04-02 Biodome Dispositif de connexion entre un recipient et un contenant et ensemble pret a l'emploi comprenant un tel dispositif
US7350669B2 (en) * 2002-10-11 2008-04-01 Novartis Ag Closure device for flexible pouches
US7470262B2 (en) * 2003-03-17 2008-12-30 Nipro Corporation Medical valve
US7470265B2 (en) * 2003-03-20 2008-12-30 Nxstage Medical, Inc. Dual access spike for infusate bags
US7040598B2 (en) * 2003-05-14 2006-05-09 Cardinal Health 303, Inc. Self-sealing male connector
US7025389B2 (en) * 2003-06-06 2006-04-11 Baxter International Inc. Method and device for transferring fluid
US20070066965A1 (en) * 2003-07-14 2007-03-22 Coambs David J Coupling device for medical lines
US20050090805A1 (en) * 2003-10-28 2005-04-28 Shaw Scott R. Reconnectable disconnect device for fluid transfer line
ITTO20040524A1 (it) * 2004-07-27 2004-10-27 Borla Ind Connettore valvolareper linee medicali di infusione
DE102004044288A1 (de) * 2004-09-10 2006-04-06 Haindl, Hans, Dr.med. Vorrichtung zur Verbindung eines rohrförmigen Teils, insbesondere einer Kanüle, mit dem Inneren einer Flasche oder dergleichen
US7192423B2 (en) * 2004-11-17 2007-03-20 Cindy Wong Dispensing spike assembly with removable indicia bands
US7645274B2 (en) * 2004-12-10 2010-01-12 Cardinal Health 303, Inc. Self-sealing male luer connector with multiple seats
US7396051B2 (en) * 2005-01-14 2008-07-08 Baxa Corporation Swabable fluid connectors and fluid connector pairs
CA2551995C (fr) * 2005-07-13 2013-12-03 Baxter International Inc. Materiaux elastomeres de presse-garniture possedant de meilleures proprietes lubrifiantes ou une meilleure aptitude au mouillage ou une meilleure activite antithrombine, ou toutesces qualites, et pouvant etre utilises dans des dispositifs du type luer (lad)
US7503908B2 (en) * 2005-07-22 2009-03-17 B. Braun Medical Inc. Needleless access port valves
US7626864B2 (en) * 2006-04-26 2009-12-01 Chih-Hsin Wang Electrically alterable non-volatile memory cells and arrays
US7473246B2 (en) 2006-06-22 2009-01-06 Baxter International Inc. Medicant reconstitution container and system
US8167863B2 (en) * 2006-10-16 2012-05-01 Carefusion 303, Inc. Vented vial adapter with filter for aerosol retention
US20090270832A1 (en) 2008-04-23 2009-10-29 Baxter International Inc. Needleless port assembly for a container
US8062280B2 (en) 2008-08-19 2011-11-22 Baxter Healthcare S.A. Port assembly for use with needleless connector

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2010022068A2 *

Also Published As

Publication number Publication date
CA2732838A1 (fr) 2010-02-25
WO2010022068A2 (fr) 2010-02-25
WO2010022068A3 (fr) 2010-06-17
US8486044B2 (en) 2013-07-16
US20100049160A1 (en) 2010-02-25
US8062280B2 (en) 2011-11-22
US20100108681A1 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
US8486044B2 (en) Port assembly for use with needleless connector
EP2309968B1 (fr) Ensemble orifice pour utilisation avec un raccord sans aiguille
US7905873B2 (en) Port assembly for use with needleless connector
US11684548B2 (en) Pooling device for single or multiple medical containers
US8647312B2 (en) Injection site for male luer or other tubular connector
US8074964B2 (en) Luer activated medical connector having a low priming volume
EP2331191B1 (fr) Dispositif luer mâle clos destiné à minimiser les fuites lors d'une connexion et d'une déconnexion
US7025744B2 (en) Injection site for male luer or other tubular connector
US6142446A (en) Medical adapter having needleless valve and sharpened cannula
EP0998325B1 (fr) Raccord sans aiguille
EP0684050A2 (fr) Accès pour l'injection sans aiguille équipé d'une valve de dérivation
PL181486B1 (pl) Z a w ó r z la c z k i PL
JP2014521453A (ja) 圧潰可能な弾性膜を有する無針コネクター器具及び対応する方法
WO2004062721A1 (fr) Soupape d'etancheite, port de connexion, tube d'alimentation de melange, dispositif de connexion pour circuits de perfusion de liquides, et systeme de connexion pour circuits de perfusion de liquides destines a un dispositif medical
WO2017217105A1 (fr) Capuchon d'aspiration d'air
KR20110003950A (ko) 약화사고 방지를 위한 주사액 혼합용 안전 소켓 및 이를 포함하는 수액 키트
JP6741209B2 (ja) フィルタ組立品
US20180193630A1 (en) Non-luer compatible administration port
AU731365B2 (en) Medical adapter
MXPA00000438A (es) Conector sin aguja

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110317

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

AX Request for extension of the european patent

Extension state: AL BA RS

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20130311

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170301